Steve Beuchaw analyst

Currently out of the existing stock ratings of Steve Beuchaw, 54 are a HOLD (39.42%), 30 are a SELL (21.9%), 53 are a BUY (38.69%).

Steve Beuchaw

Work Performance Price Targets & Ratings Chart

Analyst Steve Beuchaw, has had 72.55% of price targets met with an average potential upside of 18.5%, reached in 293 days on average. Previously, Steve Beuchaw worked at MORGAN STANLEY, WOLFE.

Steve Beuchaw has documented 258 price targets and ratings displayed on 26 stocks. The coverage was on the Healthcare sector.

Most recent stock forecast was given on QGEN, Qiagen NV at 04-Aug-2024.

Wall Street Analyst Steve Beuchaw

Analyst best performing recommendations are on ALGN (ALIGN TECHNOLOGY).
The best stock recommendation documented was for ALGN (ALIGN TECHNOLOGY) on 10/9/2018. The price target of $320 was fulfilled within 1 day with a profit of $20.97 (6.15%), with a performance score of 61.5.

Average potential price target upside

ALGN Align Technology BRKR Bruker ILMN Illumina ISRG Intuitive Surgical MDT Medtronic PLC QGEN Qiagen NV SDC SmileDirectClub XRAY Dentsply Sirona A Agilent Technologies TMO Thermo Fisher Scientific DHR Danaher HSIC Henry Schein MYGN Myriad Genetics OCDX Ortho Clinical Diagnostics Holdings plc PDCO Patterson Companies MTD Mettler-Toledo International PKI PerkinElmer VAR Varian Medical Systems NTRA Natera BIO Bio-Rad Laboratories ABT Abbott Laboratories BSX Boston Scientific Corp EW Edwards Lifesciences Corp SYK Stryker ZBH Zimmer Biomet Holdings RVTY Revvity

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold Since 21-Oct-2025

$175

$6.68 (3.97%)

$188

21 days ago
(29-Oct-2026)

25/38 (65.79%)

$21.29 (13.85%)

134

Buy Since 25-Mar-2025

$200

$31.68 (18.82%)

$200

28 days ago
(22-Oct-2026)

11/17 (64.71%)

$44.49 (28.61%)

180

Buy Since 01-May-2025

$205

$36.68 (21.79%)

$235

29 days ago
(21-Oct-2026)

17/57 (29.82%)

$53.63 (35.43%)

95

Buy Since 18-Oct-2017

$162

$-6.32 (-3.75%)

$250

1 months 4 days ago
(15-Oct-2026)

21/30 (70%)

$12.66 (8.48%)

97

Buy Since 17-Oct-2025

$215

$46.68 (27.73%)

$172

1 months 5 days ago
(14-Oct-2026)

3/5 (60%)

$70.56 (48.85%)

40

Show more analysts

Please expand the browser size to see the chart

✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?